Yarchoan M - Search Results

1

Who will manage American patients with diabetes? Residents' career preferences and perceptions of diabetes care.

Yarchoan M, Dougan ML, Tjota MY, Milliner BH, Adler BL, Armah KA, Gooley TA, Close KL, Close J, Hirsch IB. Yarchoan M, et al. Endocr Pract. 2011 Mar-Apr;17(2):235-9. doi: 10.4158/EP10250.OR. Endocr Pract. 2011. PMID: 21041164

2

Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.

Adler BL, Yarchoan M, Hwang HM, Louneva N, Blair JA, Palm R, Smith MA, Lee HG, Arnold SE, Casadesus G. Adler BL, et al. Among authors: yarchoan m. Neurobiol Aging. 2014 Apr;35(4):793-801. doi: 10.1016/j.neurobiolaging.2013.10.076. Epub 2013 Oct 11. Neurobiol Aging. 2014. PMID: 24239383

3

BRAF mutation and thyroid cancer recurrence.

Yarchoan M, LiVolsi VA, Brose MS. Yarchoan M, et al. J Clin Oncol. 2015 Jan 1;33(1):7-8. doi: 10.1200/JCO.2014.59.3657. Epub 2014 Nov 24. J Clin Oncol. 2015. PMID: 25422487 No abstract available.

4

Reply to C. Bal et al and M. Xing.

Yarchoan M, LiVolsi VA, Brose MS. Yarchoan M, et al. J Clin Oncol. 2015 Aug 1;33(22):2483. doi: 10.1200/JCO.2015.61.4859. Epub 2015 Jun 29. J Clin Oncol. 2015. PMID: 26124481 No abstract available.

5

Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease.

Yarchoan M, Arnold SE. Yarchoan M, et al. Diabetes. 2014 Jul;63(7):2253-61. doi: 10.2337/db14-0287. Epub 2014 Jun 15. Diabetes. 2014. PMID: 24931035 Free PMC article. Review.

6

Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis.

Osipov A, Lim SJ, Popovic A, Azad NS, Laheru DA, Zheng L, Jaffee EM, Wang H, Yarchoan M. Osipov A, et al. Among authors: yarchoan m. Clin Cancer Res. 2020 Sep 15;26(18):4842-4851. doi: 10.1158/1078-0432.CCR-20-0458. Epub 2020 Jun 25. Clin Cancer Res. 2020. PMID: 32586938 Free PMC article.

7

Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis.

Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, Yarchoan M, Chen J, Voltaggio L, Parian A, Lazarev M, Lauwers GY, Pawlik TM, Montgomery EA, Jaffee E, Le DT, Taube JM, Anders RA. Adler BL, et al. Among authors: yarchoan m. J Intern Med. 2018 Jun;283(6):568-577. doi: 10.1111/joim.12744. Epub 2018 Mar 24. J Intern Med. 2018. PMID: 29464806 Free PMC article.

8

Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.

Yarchoan M, Toledo JB, Lee EB, Arvanitakis Z, Kazi H, Han LY, Louneva N, Lee VM, Kim SF, Trojanowski JQ, Arnold SE. Yarchoan M, et al. Acta Neuropathol. 2014 Nov;128(5):679-89. doi: 10.1007/s00401-014-1328-5. Epub 2014 Aug 9. Acta Neuropathol. 2014. PMID: 25107476 Free PMC article.

9

Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease.

Yarchoan M, Louneva N, Xie SX, Swenson FJ, Hu W, Soares H, Trojanowski JQ, Lee VM, Kling MA, Shaw LM, Chen-Plotkin A, Wolk DA, Arnold SE. Yarchoan M, et al. J Neurol Sci. 2013 Oct 15;333(1-2):9-12. doi: 10.1016/j.jns.2013.05.028. Epub 2013 Aug 23. J Neurol Sci. 2013. PMID: 23978419 Free PMC article.

10

Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, Van Deerlin V, Lee VM, Trojanowski JQ, Arnold SE. Yarchoan M, et al. Brain. 2012 Dec;135(Pt 12):3749-56. doi: 10.1093/brain/aws271. Epub 2012 Nov 30. Brain. 2012. PMID: 23204143 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters